Home Markets Neuraxis stock rises after FDA clearance for abdominal pain treatment Neuraxis stock rises after FDA clearance for abdominal pain treatment Andrew M Oct 24, 2025 comments off Tweet on Twitter Share on Facebook Google+ Pinterest Original source: https://www.investing.com/news/stock-market-news/neuraxis-stock-rises-after-fda-clearance-for-abdominal-pain-treatment-93CH-4307803 abdominal pain FDA Market Updates NEURAXIS